Related Experiment Video
Updated: Jul 16, 2026
09:31
Generation of Induced-pluripotent Stem Cells Using Fibroblast-like Synoviocytes Isolated from Joints of Rheumatoid Arthritis Patients
Published on: October 16, 2016
9.9K
[Rheumatoid arthritis]
E Neumann1, K Frommer2, M Diller2
1Rheumatologie und Klinische Immunologie, Campus Kerckhoff, Justus-Liebig-Universität Gießen, Benekestr. 2-8, 61231, Bad Nauheim, Deutschland. e.neumann@kerckhoff-klinik.de.
Zeitschrift Fur Rheumatologie
|July 6, 2018
Summary
Rheumatoid arthritis (RA) is a chronic joint disease driven by inflammation and immune cells. Understanding its complex molecular mechanisms is key to developing new therapies for patients who do not fully benefit from current treatments.
Area of Science:
- Immunology
- Rheumatology
- Molecular Biology
Background:
- Rheumatoid arthritis (RA) is a chronic, progressive systemic connective tissue disease.
- RA primarily affects joints, causing destructive alterations due to synovial inflammation and immune cell activation.
- Cytokines, chemokines, and growth factors are central to RA's chronic inflammatory processes.
Purpose of the Study:
- To review recent insights into the molecular mechanisms of rheumatoid arthritis.
- To highlight the roles of various immune and local cells in RA pathogenesis.
- To emphasize the need for expanded therapeutic options due to patient heterogeneity.
Main Methods:
- This is an overview, summarizing current scientific literature and recent findings.
- It focuses on cellular and immunological processes in RA.
- It discusses the molecular mechanisms driving inflammation and tissue damage.
Main Results:
- Inflammatory cells (T cells, B cells, neutrophils, macrophages) and local cells (fibroblasts, osteoclasts) are activated in RA.
- These cells release mediators that drive inflammation and destruction of cartilage and bone.
- Patient heterogeneity necessitates new therapeutic strategies beyond general immune suppression.
Conclusions:
- RA involves complex, interwoven cellular and immunological pathways leading to irreversible joint destruction.
- Targeting key molecular mechanisms can reduce or halt inflammatory processes.
- Further research into novel molecular targets is crucial for developing improved RA therapies.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:23Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:21Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
01:20Rheumatic Heart Disease IV: Nursing Management
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...